|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q58236116
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000048.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q58236116
|
|
024
|
|
|
‡a
0000-0002-9748-7083
‡2
orcid
|
|
024
|
|
|
‡a
7005256125
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q58236116
|
|
100
|
0 |
|
‡a
Rodrigo F.M. de Almeida
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Rodrigo F.M. de Almeida
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A biomimetic platform to study the interactions of bioelectroactive molecules with lipid nanodomains
|
|
670
|
|
|
‡a
Author's A route to understanding yeast cellular envelope - plasma membrane lipids interplaying in cell wall integrity
|
|
670
|
|
|
‡a
Author's Biophysical Implications of Sphingosine Accumulation in Membrane Properties at Neutral and Acidic pH
|
|
670
|
|
|
‡a
Author's Biophysical properties of ergosterol-enriched lipid rafts in yeast and tools for their study: characterization of ergosterol/phosphatidylcholine membranes with three fluorescent membrane probes.
|
|
670
|
|
|
‡a
Author's Ceramide-domain formation and collapse in lipid rafts: membrane reorganization by an apoptotic lipid.
|
|
670
|
|
|
‡a
Author's Ceramide-platform formation and -induced biophysical changes in a fluid phospholipid membrane
|
|
670
|
|
|
‡a
Author's Changes in membrane organization upon spontaneous insertion of 2-hydroxylated unsaturated fatty acids in the lipid bilayer.
|
|
670
|
|
|
‡a
Author's Changes in the Biophysical Properties of the Cell Membrane Are Involved in the Response of to Staurosporine
|
|
670
|
|
|
‡a
Author's Cholesterol-rich fluid membranes solubilize ceramide domains: implications for the structure and dynamics of mammalian intracellular and plasma membranes.
|
|
670
|
|
|
‡a
Author's Copper(I) complexes with phosphine derived from sparfloxacin. Part II: a first insight into the cytotoxic action mode.
|
|
670
|
|
|
‡a
Author's Crystallization around solid-like nanosized docks can explain the specificity, diversity, and stability of membrane microdomains.
|
|
670
|
|
|
‡a
Author's Development of lysosome-mimicking vesicles to study the effect of abnormal accumulation of sphingosine on membrane properties.
|
|
670
|
|
|
‡a
Author's Differential targeting of membrane lipid domains by caffeic acid and its ester derivatives
|
|
670
|
|
|
‡a
Author's Ethanol effects on binary and ternary supported lipid bilayers with gel/fluid domains and lipid rafts
|
|
670
|
|
|
‡a
Author's Evaluation of EGCG Loading Capacity in DMPC Membranes
|
|
670
|
|
|
‡a
Author's Exploiting the therapeutic potential of 8-β-d-glucopyranosylgenistein: synthesis, antidiabetic activity, and molecular interaction with islet amyloid polypeptide and amyloid β-peptide (1-42).
|
|
670
|
|
|
‡a
Author's Formation and Properties of Membrane-Ordered Domains by Phytoceramide: Role of Sphingoid Base Hydroxylation.
|
|
670
|
|
|
‡a
Author's Formation of ceramide/sphingomyelin gel domains in the presence of an unsaturated phospholipid: a quantitative multiprobe approach.
|
|
670
|
|
|
‡a
Author's Gel domains in the plasma membrane of Saccharomyces cerevisiae: highly ordered, ergosterol-free, and sphingolipid-enriched lipid rafts.
|
|
670
|
|
|
‡a
Author's Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies
|
|
670
|
|
|
‡a
Author's Interaction of peptides with binary phospholipid membranes: application of fluorescence methodologies.
|
|
670
|
|
|
‡a
Author's Is there a preferential interaction between cholesterol and tryptophan residues in membrane proteins?
|
|
670
|
|
|
‡a
Author's Lateral distribution of the transmembrane domain of influenza virus hemagglutinin revealed by time-resolved fluorescence imaging.
|
|
670
|
|
|
‡a
Author's Lipid rafts have different sizes depending on membrane composition: a time-resolved fluorescence resonance energy transfer study.
|
|
670
|
|
|
‡a
Author's Mammalian sphingoid bases: Biophysical, physiological and pathological properties
|
|
670
|
|
|
‡a
Author's Membrane lipid domains and rafts: current applications of fluorescence lifetime spectroscopy and imaging.
|
|
670
|
|
|
‡a
Author's Modulation of plasma membrane lipid profile and microdomains by H2O2 in Saccharomyces cerevisiae.
|
|
670
|
|
|
‡a
Author's New anticandidal Cu(i) complexes with neocuproine and ketoconazole derived diphenyl(aminomethyl)phosphane: luminescence properties for detection in fungal cells
|
|
670
|
|
|
‡a
Author's New diphenylphosphane derivatives of ketoconazole are promising antifungal agents
|
|
670
|
|
|
‡a
Author's New polydentate Ru(III)-Salan complexes: Synthesis, characterization, anti-tumour activity and interaction with human serum proteins
|
|
670
|
|
|
‡a
Author's Organization and dynamics of Fas transmembrane domain in raft membranes and modulation by ceramide.
|
|
670
|
|
|
‡a
Author's Phospholipid/cholesterol/decanethiol mixtures for direct assembly of immunosensing interfaces.
|
|
670
|
|
|
‡a
Author's Quercetin dual interaction at the membrane level
|
|
670
|
|
|
‡a
Author's Reorganization of plasma membrane lipid domains during conidial germination.
|
|
670
|
|
|
‡a
Author's [RuII(η⁵-C₅H₅)(bipy)(PPh₃)]⁺, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin.
|
|
670
|
|
|
‡a
Author's Sphingolipid-enriched domains in fungi
|
|
670
|
|
|
‡a
Author's Sphingolipid hydroxylation in mammals, yeast and plants - An integrated view
|
|
670
|
|
|
‡a
Author's Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy.
|
|
670
|
|
|
‡a
Author's Structural and dynamic characterization of the interaction of the putative fusion peptide of the S2 SARS-CoV virus protein with lipid membranes.
|
|
670
|
|
|
‡a
Author's Structure and dynamics of the gammaM4 transmembrane domain of the acetylcholine receptor in lipid bilayers: insights into receptor assembly and function.
|
|
670
|
|
|
‡a
Author's Sugar-based bactericides targeting phosphatidylethanolamine-enriched membranes
|
|
670
|
|
|
‡a
Author's The extracellular matrix modulates H2O2 degradation and redox signaling in endothelial cells
|
|
670
|
|
|
‡a
Author's The molecular mechanism of Nystatin action is dependent on the membrane biophysical properties and lipid composition.
|
|
670
|
|
|
‡a
Author's The photophysics of a Rhodamine head labeled phospholipid in the identification and characterization of membrane lipid phases
|
|
670
|
|
|
‡a
Author's The role of membrane fatty acid remodeling in the antitumor mechanism of action of 2-hydroxyoleic acid.
|
|
670
|
|
|
‡a
Author's Unveiling the Mechanism of Action of 7α-acetoxy-6β-hydroxyroyleanone on an MRSA/VISA Strain: Membrane and Cell Wall Interactions
|
|
670
|
|
|
‡a
Author's VPAC1 and VPAC2 receptor activation on GABA release from hippocampal nerve terminals involve several different signalling pathways.
|
|
909
|
|
|
‡a
(scopus) 7005256125
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000297487083
‡9
1
|
|
919
|
|
|
‡a
cholesterolrichfluidmembranessolubilizeceramidedomainsimplicationsforthestructureanddynamicsofmammalianintracellularandplasmamembranes
‡A
Cholesterol-rich fluid membranes solubilize ceramide domains: implications for the structure and dynamics of mammalian intracellular and plasma membranes.
‡9
1
|
|
919
|
|
|
‡a
crystallizationaroundsolidlikenanosizeddockscanexplainthespecificitydiversityandstabilityofmembranemicrodomains
‡A
Crystallization around solid-like nanosized docks can explain the specificity, diversity, and stability of membrane microdomains.
‡9
1
|
|
919
|
|
|
‡a
changesinthebiophysicalpropertiesofthecellmembraneareinvolvedintheresponseoftostaurosporine
‡A
Changes in the Biophysical Properties of the Cell Membrane Are Involved in the Response of to Staurosporine
‡9
1
|
|
919
|
|
|
‡a
changesinmembraneorganizationuponspontaneousinsertionof2hydroxylatedunsaturatedfattyacidsinthelipidbilayer
‡A
Changes in membrane organization upon spontaneous insertion of 2-hydroxylated unsaturated fatty acids in the lipid bilayer.
‡9
1
|
|
919
|
|
|
‡a
ceramideplatformformationandinducedbiophysicalchangesinafluidphospholipidmembrane
‡A
Ceramide-platform formation and -induced biophysical changes in a fluid phospholipid membrane
‡9
1
|
|
919
|
|
|
‡a
ceramidedomainformationandcollapseinlipidraftsmembranereorganizationbyanapoptoticlipid
‡A
Ceramide-domain formation and collapse in lipid rafts: membrane reorganization by an apoptotic lipid.
‡9
1
|
|
919
|
|
|
‡a
developmentoflysosomemimickingvesiclestostudytheeffectofabnormalaccumulationofsphingosineonmembraneproperties
‡A
Development of lysosome-mimicking vesicles to study the effect of abnormal accumulation of sphingosine on membrane properties.
‡9
1
|
|
919
|
|
|
‡a
differentialtargetingofmembranelipiddomainsbycaffeicacidanditsesterderivatives
‡A
Differential targeting of membrane lipid domains by caffeic acid and its ester derivatives
‡9
1
|
|
919
|
|
|
‡a
biophysicalpropertiesofergosterolenrichedlipidraftsinyeastandtoolsfortheirstudycharacterizationofergosterolphosphatidylcholinemembraneswith3fluorescentmembraneprobes
‡A
Biophysical properties of ergosterol-enriched lipid rafts in yeast and tools for their study: characterization of ergosterol/phosphatidylcholine membranes with three fluorescent membrane probes.
‡9
1
|
|
919
|
|
|
‡a
ethanoleffectsonbinaryandternarysupportedlipidbilayerswithgelfluiddomainsandlipidrafts
‡A
Ethanol effects on binary and ternary supported lipid bilayers with gel/fluid domains and lipid rafts
‡9
1
|
|
919
|
|
|
‡a
biophysicalimplicationsofsphingosineaccumulationinmembranepropertiesatneutralandacidicph
‡A
Biophysical Implications of Sphingosine Accumulation in Membrane Properties at Neutral and Acidic pH
‡9
1
|
|
919
|
|
|
‡a
routetounderstandingyeastcellularenvelopeplasmamembranelipidsinterplayingincellwallintegrity
‡A
A route to understanding yeast cellular envelope - plasma membrane lipids interplaying in cell wall integrity
‡9
1
|
|
919
|
|
|
‡a
evaluationofegcgloadingcapacityindmpcmembranes
‡A
Evaluation of EGCG Loading Capacity in DMPC Membranes
‡9
1
|
|
919
|
|
|
‡a
biomimeticplatformtostudytheinteractionsofbioelectroactivemoleculeswithlipidnanodomains
‡A
A biomimetic platform to study the interactions of bioelectroactive molecules with lipid nanodomains
‡9
1
|
|
919
|
|
|
‡a
exploitingthetherapeuticpotentialof8β500glucopyranosylgenisteinsynthesisantidiabeticactivityandmolecularinteractionwithisletamyloidpolypeptideandamyloidβpeptide142
‡A
Exploiting the therapeutic potential of 8-β-d-glucopyranosylgenistein: synthesis, antidiabetic activity, and molecular interaction with islet amyloid polypeptide and amyloid β-peptide (1-42).
‡9
1
|
|
919
|
|
|
‡a
formationandpropertiesofmembraneordereddomainsbyphytoceramideroleofsphingoidbasehydroxylation
‡A
Formation and Properties of Membrane-Ordered Domains by Phytoceramide: Role of Sphingoid Base Hydroxylation.
‡9
1
|
|
919
|
|
|
‡a
formationofceramidesphingomyelingeldomainsinthepresenceofanunsaturatedphospholipidaquantitativemultiprobeapproach
‡A
Formation of ceramide/sphingomyelin gel domains in the presence of an unsaturated phospholipid: a quantitative multiprobe approach.
‡9
1
|
|
919
|
|
|
‡a
geldomainsintheplasmamembraneofsaccharomycescerevisiaehighlyorderedergosterolfreeandsphingolipidenrichedlipidrafts
‡A
Gel domains in the plasma membrane of Saccharomyces cerevisiae: highly ordered, ergosterol-free, and sphingolipid-enriched lipid rafts.
‡9
1
|
|
919
|
|
|
‡a
insightsintothemechanismsunderlyingtheantiproliferativepotentialofaco2coordinationcompoundbearing110phenanthroline56dionednaandproteininteractionstudies
‡A
Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies
‡9
1
|
|
919
|
|
|
‡a
interactionofpeptideswithbinaryphospholipidmembranesapplicationoffluorescencemethodologies
‡A
Interaction of peptides with binary phospholipid membranes: application of fluorescence methodologies.
‡9
1
|
|
919
|
|
|
‡a
isthereapreferentialinteractionbetweencholesterolandtryptophanresiduesinmembraneproteins
‡A
Is there a preferential interaction between cholesterol and tryptophan residues in membrane proteins?
‡9
1
|
|
919
|
|
|
‡a
lateraldistributionofthetransmembranedomainofinfluenzavirushemagglutininrevealedbytimeresolvedfluorescenceimaging
‡A
Lateral distribution of the transmembrane domain of influenza virus hemagglutinin revealed by time-resolved fluorescence imaging.
‡9
1
|
|
919
|
|
|
‡a
lipidraftshavedifferentsizesdependingonmembranecompositionatimeresolvedfluorescenceresonanceenergytransferstudy
‡A
Lipid rafts have different sizes depending on membrane composition: a time-resolved fluorescence resonance energy transfer study.
‡9
1
|
|
919
|
|
|
‡a
mammaliansphingoidbasesbiophysicalphysiologicalandpathologicalproperties
‡A
Mammalian sphingoid bases: Biophysical, physiological and pathological properties
‡9
1
|
|
919
|
|
|
‡a
membranelipiddomainsandraftscurrentapplicationsoffluorescencelifetimespectroscopyandimaging
‡A
Membrane lipid domains and rafts: current applications of fluorescence lifetime spectroscopy and imaging.
‡9
1
|
|
919
|
|
|
‡a
modulationofplasmamembranelipidprofileandmicrodomainsbyh2o2insaccharomycescerevisiae
‡A
Modulation of plasma membrane lipid profile and microdomains by H2O2 in Saccharomyces cerevisiae.
‡9
1
|
|
919
|
|
|
‡a
newanticandidalcu1complexeswithneocuproineandketoconazolederiveddiphenylaminomethylphosphaneluminescencepropertiesfordetectioninfungalcells
‡A
New anticandidal Cu(i) complexes with neocuproine and ketoconazole derived diphenyl(aminomethyl)phosphane: luminescence properties for detection in fungal cells
‡9
1
|
|
919
|
|
|
‡a
newdiphenylphosphanederivativesofketoconazolearepromisingantifungalagents
‡A
New diphenylphosphane derivatives of ketoconazole are promising antifungal agents
‡9
1
|
|
919
|
|
|
‡a
newpolydentateru3salancomplexessynthesischaracterizationantitumouractivityandinteractionwithhumanserumproteins
‡A
New polydentate Ru(III)-Salan complexes: Synthesis, characterization, anti-tumour activity and interaction with human serum proteins
‡9
1
|
|
919
|
|
|
‡a
organizationanddynamicsoffastransmembranedomaininraftmembranesandmodulationbyceramide
‡A
Organization and dynamics of Fas transmembrane domain in raft membranes and modulation by ceramide.
‡9
1
|
|
919
|
|
|
‡a
phospholipidcholesteroldecanethiolmixturesfordirectassemblyofimmunosensinginterfaces
‡A
Phospholipid/cholesterol/decanethiol mixtures for direct assembly of immunosensing interfaces.
‡9
1
|
|
919
|
|
|
‡a
quercetindualinteractionatthemembranelevel
‡A
Quercetin dual interaction at the membrane level
‡9
1
|
|
919
|
|
|
‡a
reorganizationofplasmamembranelipiddomainsduringconidialgermination
‡A
Reorganization of plasma membrane lipid domains during conidial germination.
‡9
1
|
|
919
|
|
|
‡a
+apromisinglargespectrumantitumoragentcytotoxicactivityandinteractionwithhumanserumalbumin
‡A
[RuII(η⁵-C₅H₅)(bipy)(PPh₃)]⁺, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin.
‡9
1
|
|
919
|
|
|
‡a
sphingolipidenricheddomainsinfungi
‡A
Sphingolipid-enriched domains in fungi
‡9
1
|
|
919
|
|
|
‡a
sphingolipidhydroxylationinmammalsyeastandplantsanintegratedview
‡A
Sphingolipid hydroxylation in mammals, yeast and plants - An integrated view
‡9
1
|
|
919
|
|
|
‡a
sphingomyelinandsphingomyelinsynthasesmsinthemalignanttransformationofgliomacellsandin2hydroxyoleicacidtherapy
‡A
Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy.
‡9
1
|
|
919
|
|
|
‡a
structuralanddynamiccharacterizationoftheinteractionoftheputativefusionpeptideofthes2sarscovvirusproteinwithlipidmembranes
‡A
Structural and dynamic characterization of the interaction of the putative fusion peptide of the S2 SARS-CoV virus protein with lipid membranes.
‡9
1
|
|
919
|
|
|
‡a
structureanddynamicsofthegammam4transmembranedomainoftheacetylcholinereceptorinlipidbilayersinsightsintoreceptorassemblyandfunction
‡A
Structure and dynamics of the gammaM4 transmembrane domain of the acetylcholine receptor in lipid bilayers: insights into receptor assembly and function.
‡9
1
|
|
919
|
|
|
‡a
sugarbasedbactericidestargetingphosphatidylethanolamineenrichedmembranes
‡A
Sugar-based bactericides targeting phosphatidylethanolamine-enriched membranes
‡9
1
|
|
919
|
|
|
‡a
extracellularmatrixmodulatesh2o2degradationandredoxsignalinginendothelialcells
‡A
The extracellular matrix modulates H2O2 degradation and redox signaling in endothelial cells
‡9
1
|
|
919
|
|
|
‡a
molecularmechanismofnystatinactionisdependentonthemembranebiophysicalpropertiesandlipidcomposition
‡A
The molecular mechanism of Nystatin action is dependent on the membrane biophysical properties and lipid composition.
‡9
1
|
|
919
|
|
|
‡a
photophysicsofarhodamineheadlabeledphospholipidintheidentificationandcharacterizationofmembranelipidphases
‡A
The photophysics of a Rhodamine head labeled phospholipid in the identification and characterization of membrane lipid phases
‡9
1
|
|
919
|
|
|
‡a
roleofmembranefattyacidremodelingintheantitumormechanismofactionof2hydroxyoleicacid
‡A
The role of membrane fatty acid remodeling in the antitumor mechanism of action of 2-hydroxyoleic acid.
‡9
1
|
|
919
|
|
|
‡a
unveilingthemechanismofactionof7αacetoxy6βhydroxyroyleanoneonanmrsavisastrainmembraneandcellwallinteractions
‡A
Unveiling the Mechanism of Action of 7α-acetoxy-6β-hydroxyroyleanone on an MRSA/VISA Strain: Membrane and Cell Wall Interactions
‡9
1
|
|
919
|
|
|
‡a
vpac1andvpac2receptoractivationongabareleasefromhippocampalnerveterminalsinvolveseveraldifferentsignallingpathways
‡A
VPAC1 and VPAC2 receptor activation on GABA release from hippocampal nerve terminals involve several different signalling pathways.
‡9
1
|
|
919
|
|
|
‡a
copper1complexeswithphosphinederivedfromsparfloxacinpart2a1insightintothecytotoxicactionmode
‡A
Copper(I) complexes with phosphine derived from sparfloxacin. Part II: a first insight into the cytotoxic action mode.
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
PTBNP|2269
|
|
996
|
|
|
‡2
RERO|A002920842
|
|
996
|
|
|
‡2
DNB|1231309288
|
|
996
|
|
|
‡2
LC|no2013001796
|
|
996
|
|
|
‡2
LC|n 97087670
|
|
996
|
|
|
‡2
ISNI|0000000040197988
|
|
996
|
|
|
‡2
ISNI|0000000070907266
|
|
996
|
|
|
‡2
DNB|1028063504
|
|
996
|
|
|
‡2
PTBNP|2265
|
|
996
|
|
|
‡2
PTBNP|2274
|
|
996
|
|
|
‡2
DNB|1060758512
|
|
996
|
|
|
‡2
LC|no2013066942
|
|
996
|
|
|
‡2
SUDOC|070125139
|
|
996
|
|
|
‡2
BLBNB|001009722
|
|
996
|
|
|
‡2
BNF|17939626
|
|
996
|
|
|
‡2
BLBNB|001028546
|
|
996
|
|
|
‡2
DNB|135948703
|
|
996
|
|
|
‡2
SUDOC|184992575
|
|
996
|
|
|
‡2
BLBNB|000466589
|
|
996
|
|
|
‡2
PTBNP|39273
|
|
996
|
|
|
‡2
ISNI|0000000361550789
|
|
996
|
|
|
‡2
BLBNB|000309175
|
|
996
|
|
|
‡2
LC|n 2014204844
|
|
996
|
|
|
‡2
LC|n 2011213846
|
|
996
|
|
|
‡2
ISNI|0000000430811488
|
|
996
|
|
|
‡2
BNF|17904292
|
|
996
|
|
|
‡2
NUKAT|n 2020021650
|
|
996
|
|
|
‡2
DNB|1035292890
|
|
996
|
|
|
‡2
ISNI|0000000400035174
|
|
996
|
|
|
‡2
DNB|1055470557
|
|
996
|
|
|
‡2
BLBNB|000403591
|
|
996
|
|
|
‡2
ISNI|0000000070525161
|
|
996
|
|
|
‡2
ISNI|0000000068202275
|
|
996
|
|
|
‡2
ISNI|0000000066635579
|
|
996
|
|
|
‡2
DNB|1295943638
|
|
996
|
|
|
‡2
BLBNB|001515926
|
|
996
|
|
|
‡2
BNF|15508907
|
|
996
|
|
|
‡2
LC|no2012048800
|
|
996
|
|
|
‡2
DNB|1160898154
|
|
996
|
|
|
‡2
LC|n 2007207361
|
|
996
|
|
|
‡2
ISNI|0000000068118153
|
|
996
|
|
|
‡2
BLBNB|001426975
|
|
996
|
|
|
‡2
SUDOC|179859447
|
|
996
|
|
|
‡2
DNB|1159115060
|
|
996
|
|
|
‡2
LC|n 92112859
|
|
996
|
|
|
‡2
SUDOC|228524814
|
|
996
|
|
|
‡2
DNB|1329424018
|
|
996
|
|
|
‡2
DNB|111549726X
|
|
996
|
|
|
‡2
BLBNB|000986926
|
|
996
|
|
|
‡2
PTBNP|1198450
|
|
996
|
|
|
‡2
ISNI|0000000066857729
|
|
996
|
|
|
‡2
DNB|1147811113
|
|
996
|
|
|
‡2
BLBNB|001431799
|
|
996
|
|
|
‡2
BLBNB|000551407
|
|
996
|
|
|
‡2
SUDOC|119080176
|
|
996
|
|
|
‡2
CAOONL|ncf10731146
|
|
996
|
|
|
‡2
PLWABN|9812710297005606
|
|
996
|
|
|
‡2
ISNI|0000000433839216
|
|
996
|
|
|
‡2
LC|n 2024253274
|
|
996
|
|
|
‡2
ISNI|0000000068209055
|
|
996
|
|
|
‡2
NTA|391174142
|
|
996
|
|
|
‡2
SUDOC|148538681
|
|
996
|
|
|
‡2
BLBNB|001444105
|
|
996
|
|
|
‡2
LC|no2014047924
|
|
996
|
|
|
‡2
ISNI|0000000369268294
|
|
996
|
|
|
‡2
ISNI|0000000410217879
|
|
996
|
|
|
‡2
PTBNP|1475305
|
|
996
|
|
|
‡2
LC|no2024017611
|
|
996
|
|
|
‡2
BLBNB|001505775
|
|
996
|
|
|
‡2
NSK|000392624
|
|
996
|
|
|
‡2
PTBNP|96828
|
|
996
|
|
|
‡2
DNB|1213302994
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
